Read More

Canopy Growth Announces $250M At-The-Market Equity Program

Canopy Growth Corporation (NASDAQ: CGC) announced on Thursday that it has established an at-the-market equity program under which it can issue and sell up to $250 million worth of its common shares from treasury from time to time in concurrent public offerings in the United States and Canada.The Canadian cannabis giant said that any of its common shares sold in the ATM program will be sold in transactions made directly on the Nasdaq or the TSX or on any other available U.S. or Canadian trading market. Canopy will set the volume and timing of sales under the program, with the common shares being distributed at market prices prevailing at the time of each sale or certain other prices.

ACRHF

Read More

Acreage Announces $10M Private Placement Of Units Ahead Of Acquisition By Canopy

Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) announced on Wednesday it's seeking to secure $10 million in finding.The New York-based company said in a press release that it has entered into subscription agreements with certain institutional investors to issue units by way of a brokered private placement for $833.33 per unit.

ACRDF

Read More

Cannabis Co. C21 Investments Secures Funding For $3.5M Acquisition Of Nevada’s Deep Roots Harvest

C21 Investments announced on Monday the closing of its non-brokered private placement offering of its convertible debenture units.Under the deal, the company issued a total of 4,000 convertible debenture units at CA$1,000 ($731.375) per convertible debenture unit for aggregate gross proceeds of CA$4 million.Each convertible debenture unit offered under the private placement is comprised of one convertible debenture of the company in the principal amount of CA$1,000 convertible into the company's common shares and 1,000 detachable common share purchase warrants, with each warrant exercisable into one common share at CA$0.55 per share for 30 months from the issue date of the convertible debenture units.

CSE:CXXI

Read More

Canopy Growth Announces Financing Deal Including Roughly $50M Of New Gross Proceeds

Canopy Growth Corporation has entered into an exchange and subscription agreement with a single institutional investor under which the Smiths Falls, Ontario-based company is expected to receive gross proceeds of roughly $50 million and exchange approximately CA$27.5 million ($20 million) of existing debt maturing in September 2025 for a new senior unsecured convertible debenture of the company maturing five years following the day of issuance. Under the terms of the deal, the investor will acquire a convertible debenture in an aggregate principal amount equal to CA$96,358,375 on closing.

CGC

Read More

Cannabis REIT Chicago Atlantic Closes $20M Facility With Massachusetts Weed Co. That Plans To Expand In These Key Markets

Massachusetts-based integrated cannabis operator Nova Farms has received a $20 million loan facility from Chicago Atlantic Real Estate Finance. Nova Farms manages a Massachusetts cultivation farm, seven retail brands, and five full-service dispensaries across the Bay State, Maine, and New Jersey. It was among the first businesses to secure licenses in Massachusetts upon the state's legalization of recreational cannabis back in 2016. Chicago Atlantic's capital investment is expected to back Nova Farms' efforts to expand its footprint of dispensaries in key states, namely New Jersey and Connecticut.

REFI

Read More

Hydroponics Giant Announces $6M Share Repurchase Program, CEO Says Understanding ‘Where Every Nickel Goes’ Is Vital For Business Growth

Beginning on April 1, the share repurchase program, will continue for up to one year, allowing for repurchases to be made in the open market. Darren Lampert, the company's co-founder and CEO, explained what the move means for GrowGen. "Today's announcement of our share repurchase program further underscores our conviction in the strength of our underlying business and our view that GrowGen shares remain undervalued," Lampert said. "This program acts as one pillar of our shareholder value creation strategy as we continue to evaluate all potential uses for our strong balance sheet, including reinvesting in our brands, strategic acquisitions, and stock repurchases to enhance long-term shareholder value."

GRWG

Read More

Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal

Blueberries Medical, a Latin American licensed producer of medicinal cannabis and cannabis-derived products, has announced a non-brokered private placement, to raise approximately CA$1.9m ($1.4m). The company announced the sale of 180,716,00 common shares at CA$0.011 per share. The net proceeds from the sale will be used to repay existing debt and for general corporate and working capital purposes. The offering was led by Terraflos, a Latin American company founded and controlled by Facundo Garreton, who serves as Blueberries' chairman, CEO, and director. Terraflos is exploring opportunities in Argentina, Mexico, and Brazil and plans to expand into those markets in the near future.

ALID